Evaluation of CYP3A4-Mediated Interactions of Gefitinib and Erlotinib Using Physiologically-Based Pharmacokinetic Models
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Pharmacogenetics and Drug Metabolism
Drug Transport and Resistance Mechanisms
Lung Cancer Treatments and Mutations
Publication details
- Journal / source
- Drug Targets and Therapeutics
- Volume
- 5
- Issue
- 1
- Pages
- 12–23
- Publication date
- 30 March 2026
- Language
- EN